Key Highlights
- Linde shares fell nearly 6% despite record second-quarter sales of 9.3 billion dollars, up 9% year over year, beating the 9.0 billion dollar consensus estimate.
- Adjusted Earnings Per Share of 4.50 dollars topped the 4.49 dollar consensus, while Backlog reached a record 8.1 billion dollars after a new 1 billion dollar electronics win in the United States.
- Full-year 2026 adjusted earnings per share guidance was raised at the low end to a range of 17.70 to 17.90 dollars, below the 17.91 dollar analyst estimate.
- Operating margins declined 60 basis points year over year, driven primarily by cost Inflation and unfavorable regulatory changes affecting the company's home care Business .
Record Results Fail to Offset Cautious Forward Guidance
Linde ( Nasdaq :LIN) reported record second-quarter sales of 9.3 billion dollars, up 9% year over year and 6% sequentially, alongside record adjusted earnings per share of 4.50 dollars, up 10% year over year and modestly ahead of consensus estimates. Backlog reached a record 8.1 billion dollars following a new 1 billion dollar electronics contract win in the United States, while a separate joint venture in Taiwan is set to invest approximately 800 million dollars in air separation and hydrogen units supporting semiconductor fabrication facilities.
Despite these results, shares fell sharply as investors focused on full-year 2026 guidance that came in narrower and more modest than expected. Full-year adjusted earnings per share guidance was raised at the low end to a range of 17.70 to 17.90 dollars, representing growth of 8% to 9%, but the range fell short of the 17.91 dollar consensus estimate, suggesting the market interpreted the raise as underwhelming relative to the strength of the quarterly beat.
Margin Pressure in Home Care Business Weighs on Profitability
Operating margins declined 60 basis points year over year, or 30 basis points when excluding cost pass-through effects, with the decline driven primarily by the company's home care business, known as Lincare, which continues to face persistent headwinds from labor inflation and unfavorable reimbursement policy changes. Management indicated it is evaluating strategic Options for the segment while pursuing aggressive cost and productivity actions expected to Yield sequential improvement in the third quarter.
Growth drivers elsewhere in the business remained robust, with electronics standing out as the fastest growing end market, up 18% year over year and expected to remain the largest contributor to backlog. Aerospace accounted for more than a third of manufacturing-related growth, while the company's United States packaging business showed signs of Manufacturing recovery, with mid to high single digit gas Volume growth and double digit hard goods growth.
Helium Supply Disruption and Project Pipeline Shape the Outlook
Helium supply has been actively managed by the company despite disruptions tied to the Strait of Hormuz, with strong pricing offsetting higher dislocation costs, though the combination has created a dilutive effect on margins. Management does not expect helium market conditions to normalize until early next year, and guidance assumptions for helium supply remain unchanged from prior expectations, suggesting continued near-term margin pressure from this specific product line regardless of broader Demand trends.
Third-quarter guidance calls for adjusted earnings per share of 4.45 to 4.55 dollars, representing 6% to 8% growth, assuming a modest sequential foreign exchange headwind. The company's project pipeline includes more than 20 new project start-ups totaling approximately 1.3 billion dollars, with backlog expected to help the company finish the year within its guided range despite the near-term costs typically associated with bringing new projects online.
Conclusion
Linde's second-quarter results demonstrate continued execution strength across sales growth, record backlog and margin resilience in most segments, even as persistent challenges in its home care business and helium supply disruptions weigh on overall profitability. The market's negative reaction suggests investors placed greater weight on the modest scale of the full-year guidance raise than on the underlying quarterly beat. Whether sentiment improves may depend on the pace of margin recovery in the home care segment and the timing of helium market normalization expected in early next year.






Please wait processing your request...